Expanded risk groups help determine which prostate radiotherapy sub-group may benefit from adjuvant androgen deprivation therapy

<p>Abstract</p> <p>Purpose</p> <p>To assess whether an expanded (five level) risk stratification system can be used to identify the sub-group of intermediate risk patients with prostate cancer who benefit from combining androgen deprivation therapy (ADT) with external b...

Full description

Bibliographic Details
Main Authors: Williams Scott G, Beasley Matthew, Pickles Tom
Format: Article
Language:English
Published: BMC 2008-04-01
Series:Radiation Oncology
Online Access:http://www.ro-journal.com/content/3/1/8